Proteomics Business
Our Business Style
We aim to practical use of 「AI proteomics」technology

Established a collaborative research center on campus with the Hayashi Lab of Tokyo Institute of Technology in April 2019. AI can accurately determine protein mutations based on digital images of human and animal proteins (hereinafter referred to as proteomics images), enabling early search for biomarker candidates at drug discovery sites and obtaining evidence on the efficacy of substances.

In the future, AI proteomics technology will be introduced as a primary screening before health checkups, and appropriate workups will be encouraged to reduce diagnostic costs. Ultimately, we aim to apply this technology to sensor technology that allows easy and easy testing anytime and anywhere, and enables early detection of diseases and injuries, so that preventive measures can be taken while healthy.

AI Proteomics collaborative research center Overview
  • Director
    Hayashi Nobuhiro (Tokyo Institute of Technology of Associate Professor)
  • Location
    Tokyo Institute of Technology Okayama Campus Midorigaoka Building 6
  • Research allotment
    • Tokyo Institute of Technology: Research and utilization of AI proteomics in general
    • aiwell Inc.: Collection of AI proteomics specimens, determination of micro blood sampling flow and testing techniques for practical use
Director(Tokyo Institute of Technology of Associate Professor) NOBUHIRO HAYASHI Graduated from the Department of Physics, Faculty of Science, University of Tokyo, completed the Graduate School of Science and Engineering, Tokyo Institute of Technology (Doctor of Science). I want to understand life as an unknown physical phenomenon. We aim at the ultimate profiling of living organisms by looking at proteomics, which considers the constituents of living organisms not as an individual but as a whole system, with an eye on artificial intelligence. President, Tokyo Institute of Technology Future Sports and Health Sciences Research Promotion Organization LiHub Future Health Science Group Representative
What is AI proteomics?

AI proteomics is a technology that discovers signs and changes of all living things from changes in proteins Any technology that has protein, such as humans and animals, can be used with this technology
Effective treatment and prevention for non-illness

AI proteomics research results
  • Elucidation of the onset mechanism of atopic dermatitis
  • Elucidation of molecular mechanism of cell fusion
  • Search for biomarkers by plasma proteome analysis of gastrointestinal cancer
  • Exploring biomarkers for post-transplant complications of allogeneic hematopoietic stem cells using high-precision proteomics
  • Elucidation of the molecular mechanism of emotional activation using fish
  • A method of healthy management of bone by the balance between osteoblast and osteoclast
  • Study of genes involved in abnormal labor
  • Effects of transient exercise on appetite, appetite regulating hormone, and energy intake
  • Understanding the effects of low-level radiation on living organisms
  • Development of high-speed optical precision diagnosis of sepsis
  • Development of high-precision diagnostic method for rehabilitation
Three areas of research and development

A joint research project with a company that uses「proteomics」technology The three main areas targeted, will continue to provide support for each business